These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 38111032)

  • 1. Vaccine inequity: a threat to Africa's recovery from COVID-19.
    Wei CR; Kamande S; Lang'at GC
    Trop Med Health; 2023 Dec; 51(1):69. PubMed ID: 38111032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing COVID-19 vaccine hesitancy and barriers to uptake in Sub-Saharan Africa.
    Wollburg P; Markhof Y; Kanyanda S; Zezza A
    Commun Med (Lond); 2023 Sep; 3(1):121. PubMed ID: 37696937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State capture through indemnification demands? Effects on equity in the global distribution of COVID-19 vaccines.
    Gorodensky A; Kohler JC
    J Pharm Policy Pract; 2022 Aug; 15(1):50. PubMed ID: 35986397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid review of evidence on the determinants of and strategies for COVID-19 vaccine acceptance in low- and middle-income countries.
    Moola S; Gudi N; Nambiar D; Dumka N; Ahmed T; Sonawane IR; Kotwal A
    J Glob Health; 2021; 11():05027. PubMed ID: 34912550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions.
    Tagoe ET; Sheikh N; Morton A; Nonvignon J; Sarker AR; Williams L; Megiddo I
    Front Public Health; 2021; 9():709127. PubMed ID: 34422750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Worrying Phenomenon of COVID-19 Vaccine Hesitancy and Its Negative Impact on Pandemic Control Efforts: Common Themes that Emerged in the Middle East and North Africa (MENA) Region.
    Mahafzah A; Sallam M; Bakri FG; Mubarak MS
    Adv Exp Med Biol; 2024; 1457():299-322. PubMed ID: 39283434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine Hesitancy in Sub-Saharan Africa in the Context of COVID-19 Vaccination Exercise: A Systematic Review.
    Ochola EA
    Diseases; 2023 Feb; 11(1):. PubMed ID: 36810546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of COVID-19 vaccine acceptance and hesitancy among adolescents and youths aged 10-35 years in sub-Saharan African countries: A systematic review and meta-analysis.
    Mwiinde AM; Kaonga P; Jacobs C; Zulu JM; Fwemba I
    PLoS One; 2024; 19(10):e0310827. PubMed ID: 39374213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Vaccines: How Efficient and Equitable Was the Initial Vaccination Process?
    Das JK; Chee HY; Lakhani S; Khan MH; Islam M; Muhammad S; Bhutta ZA
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccination in low and middle-income countries: Creating a sustainable roadmap for promoting public health intervention.
    Oladapo RK; Obidiro OP; Oyetola AB; Olajide A; Oladapo MO; Lawrence US; Hasan MM; Islam Z; Mustapha AA; Osuagwu-Nwogu E; Ghazanfar S; Olaleye MA; Monisola I; Ibraheem B; Afolayan AA; Barakat A; Adewole MO
    Int J Health Plann Manage; 2024 Sep; 39(5):1612-1625. PubMed ID: 39090524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Race for Global Equitable Access to COVID-19 Vaccines.
    Md Khairi LNH; Fahrni ML; Lazzarino AI
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions to increase COVID-19 vaccine uptake: a scoping review.
    Andreas M; Iannizzi C; Bohndorf E; Monsef I; Piechotta V; Meerpohl JJ; Skoetz N
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015270. PubMed ID: 35920693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccine inequity in African low-income countries.
    Kunyenje CA; Chirwa GC; Mboma SM; Ng'ambi W; Mnjowe E; Nkhoma D; Ngwira LG; Chawani MS; Chilima B; Mitambo C; Crampin A; Mfutso-Bengo J
    Front Public Health; 2023; 11():1087662. PubMed ID: 36950103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry's Role in Widening the Access Gap.
    Borges LC; Zeferino de Menezes H; Crosbie E
    Int J Health Policy Manag; 2022 Dec; 11(12):3101-3113. PubMed ID: 36028975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward.
    Lawal L; Aminu Bello M; Murwira T; Avoka C; Yusuf Ma'aruf S; Harrison Omonhinmin I; Maluleke P; Tsagkaris C; Onyeaka H
    Hum Vaccin Immunother; 2022 Dec; 18(1):2034457. PubMed ID: 35240908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes and costs of global COVID-19 vaccine inequity.
    Ferranna M
    Semin Immunopathol; 2024 Jan; 45(4-6):469-480. PubMed ID: 37870569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case study.
    Grenfell RFQ; Oyeyemi OT
    Pathog Glob Health; 2023 Mar; 117(2):152-166. PubMed ID: 35770309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing vaccine hesitancy and resistance for COVID-19 vaccines.
    Peters MDJ
    Int J Nurs Stud; 2022 Jul; 131():104241. PubMed ID: 35489108
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.